A new study published in JCI Insight suggests that interleukin-7 (IL-7), a key immune-boosting cytokine, may help critically ill COVID-19 patients by reducing life-threatening secondary infections.

Preliminary data from the CDC shows there were 627 deaths from COVID-19 in Washington last year, for a crude rate of 8 per ...

Twenty Mass. districts were affected but two account for the majority of the unspent funds: Springfield, with $47.4 million ...

The COVID-19 pandemic has had an immediate and permanent impact on our education system. Sudden lockdowns across America in ...

"Everything still had to get done," former Neenah Mayor Dean Kaufert said. "It just had to get done in a different way." ...

Manhattan's office leasing activity during the first quarter of 2025 was the strongest quarterly volume since the fourth ...

A new study found that reported diagnoses of tuberculosis were consistently lower than expected throughout the pandemic, even ...

The St. Louis Cardinals saw the lowest non-COVID-19 attendance in the history of Busch Stadium III on Monday. A paid ...

SALISBURY, Md. – 5 years ago, the world as we knew it changed. We entered into a new normal of navigating the COVID-19 ...

While students and teachers returned to classrooms following the coronavirus lockdown, five years later, it's hard to say if ...

One instance was at Ascension Catholic Parish in Denver’s Montbello neighborhood, where in 2021, she told the masked ...

The United States government has discontinued its free at-home COVID-19 test program after four years. The program, which ...